- Home
- RDCM vs PMI Comparison
RDCM vs PMI Comparison
Compare RDCM & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDCM | PMI |
|---|---|---|
| Founded | 1985 | 1981 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.2M | 202.7M |
| IPO Year | 1997 | 2025 |
Fundamental Metrics
Financial Performance| Metric | RDCM | PMI |
|---|---|---|
| Price | $13.41 | $2.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 76.8K | ★ 2.6M |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.57 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $68,901,000.00 | $4,767,000.00 |
| Revenue This Year | $18.86 | N/A |
| Revenue Next Year | $11.39 | N/A |
| P/E Ratio | $20.99 | ★ N/A |
| Revenue Growth | ★ 17.27 | 8.81 |
| 52 Week Low | $9.88 | $1.90 |
| 52 Week High | $15.98 | $13.68 |
Technical Indicators
Market Signals| Indicator | RDCM | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | N/A |
| Support Level | $12.81 | N/A |
| Resistance Level | $13.88 | N/A |
| Average True Range (ATR) | 0.41 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 62.06 | 0.00 |
Price Performance
Historical ComparisonAbout RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.